Instrument Inactif

Cours Cadence Pharmaceuticals, Inc.

Actions

Cours en clôture Nasdaq Autres places de cotation
- ^USD	-

Actavis : Factbox - M&A frenzy transforming global pharma	06/05/14
Cadence Pharmaceuticals, Inc. : Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2013 Financial Results	28/02/14
Cadence Pharmaceuticals, Inc. : Ryan & Maniskas, LLP Announces Investigation of Cadence Pharmaceuticals Inc.	12/02/14
Cadence Pharmaceuticals, Inc. : Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Cadence Pharmaceuticals, Inc. Stockholders	11/02/14
Cadence Pharmaceuticals, Inc. : Cadence Pharmaceuticals Estimates Fourth Quarter and Full Year 2013 Product Revenue and Provides Full Year 2014 Revenue Guidance	13/01/14

Dirigeants	Titre	Age	Depuis
Bryan Reasons PSD	President	56	-
Diane K. Sheehan HRO	Human Resources Officer	54	01/05/06

Administrateurs	Titre	Age	Depuis
Bryan Reasons PSD	President	56	-
Marvin R. Haselhorst BRD	Director/Board Member	-	19/03/14

Secteur

	Varia. 1 janv.	Capi.
CSL LIMITED	-4,66 %	86,13 Md
SAMSUNG BIOLOGICS CO.,LTD.	+1,32 %	39,82 Md
BIOGEN INC.	-19,27 %	30,42 Md
UCB	+57,86 %	25,23 Md
BIOMARIN PHARMACEUTICAL INC.	-16,09 %	15,35 Md
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-9,14 %	11,95 Md
INCYTE CORPORATION	-17,69 %	11,6 Md
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-43,00 %	11,51 Md
SWEDISH ORPHAN BIOVITRUM AB	+5,24 %	8,71 Md